Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001839882-23-013973
Filing Date
2023-05-30
Accepted
2023-05-30 18:13:13
Documents
2
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1618
2 POWER OF ATTORNEY ex24.htm EX-24 7109
  Complete submission text file 0001839882-23-013973.txt   10182
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL STE 300 SAN DIEGO CA 92130
Business Address
Versi Jannine (Reporting) CIK: 0001977745 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36242 | Film No.: 23978237